Search
for
Sort by
Research 121–150 of 469
- Severe hair loss associated with psyc hotropic drugs in psychiatric inpatients—Data from an observational pharmacovigilance program in German-speaking countries
- A population-based study of the risk of osteoporosis and fracture with dutasteride and finasteride
- Cutaneous Drug Eruptions Associated with the Use of Biologies and Cutaneous Drug Eruptions Mimicking Specific Skin Diseases
- Cutaneous Reactions to Drugs
- Telogen Effluvium
- Telogen effluvium: a review
- HHV-6A and HHV-6B in Drug-Induced Hypersensitivity Syndrome/Drug Reaction with Eosinophilia and Systemic Symptoms
- A Child with Nonscarring Alopecia
- Regulation of the human hair cycle
- The Skin and Subcutaneous Tissues
- Hair Disorders
- Hair Loss in Patients on Glucagon-Like Peptide 1 Receptor Agonists: Understanding Risks and Managing Outcomes
- The Relationship Between the Use of Headscarves (Hijab) and Hair Loss (Effluvium) Prevalence in Medical Students
- Assessment of Serum Ferritin Levels in Female Patients With Telogen Effluvium
- Satoyoshi Syndrome: Difficult to find or treat?
- Hair Follicles: Strategic Targets for Promoting Hair Growth
- Real-world Experience to Understand the Use and Efficacy of Sebamed® Anti-Hair-Loss Shampoo in Managing Hair Fall
- Vitex negundo: A comprehensive review of phytoconstituents, their derivatives, and therapeutic applications
- Trichotillomania in a Male Patient With Depression: A Case Report
- The study of the range and availability of Vitamin D 3 preparations in the pharmaceutical market of Ukraine
- Evaluating the Role of Thyroid Stimulating Hormone and Ferritin Levels with Hair Loss among Patients with COVID-19: Case-Control Study
- Polycystic ovarian syndrome
- Telogen Effluvium
- Androgen effects on the skin
- The childbearing years: hair diseases
- Drug Information Analysis Service
- Melatonin membrane receptors in peripheral tissues: Distribution and functions
- Severe cutaneous adverse reactions to drugs
- Adverse Side Effects of 5α‐Reductase Inhibitors Therapy: Persistent Diminished Libido and Erectile Dysfunction and Depression in a Subset of Patients
- Historical and Current Adenosine Receptor Agonists in Preclinical and Clinical Development